| MPE | malignant proliferation of eosinophils; maximum permissible exposure; maximum possible error; Medicaid program evaluation |
|---|---|
| MPEC | monopolar electrocoagulation |
| MPED | minimum phototoxic erythema dose |
| MPEH | methylphenylethylhydantoin |
| MPE | Malignant pleural effusion |
|---|---|
| MPE | Massive pulmonary embolism |
| MPE | Mean prediction error |
| MPE | Methidiumpropyl-EDTA |
| MPE.Fe(II) | Methidiumpropyl-EDTA.Fe(II |
| MPEAK | MultiPeak |
| mPEG | Monomethoxy polyethylene glycol |
| MPEG | methoxy poly(ethylene glycol |
| MPEP | 2-methyl-6-(phenylethynyl)-pyridine |
| % MPE | Maximal possible effects |
|---|---|
| % MPE | maximum possible effect |
Á¦Ç°¸í |
ÆÇ¸Å»ç |
º¸ÇèÄÚµå | ¼ººÐ/ÇÔ·® | ±¸ºÐ/º¸Çè±Þ¿© |
|---|
Á¦Ç°¸í |
ÆÇ¸Å»ç |
º¸ÇèÄÚµå | ¼ººÐ/ÇÔ·® | ±¸ºÐ/º¸Çè±Þ¿© |
|---|